Jochem Potenberg

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Epidermal Growth Factor Receptor

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Nadia Harbeck, Ulrike A Nitz, Matthias Christgen, Sherko Kuemmel, Michael Braun, Claudia Schumacher, Jochem Potenberg, Joke Tio, Bahriye Aktaş, Helmut Forstbauer, Eva-Maria Grischke, Iris Scheffen, Wolfram Malter, Raquel von Schumann, Marianne Just, Christine Zu Eulenburg, Claudia Biehl, Cornelia Kolberg-Liedtke, Regula Deurloo, Sanne de Haas, Katarzyna Jóźwiak, Michael Hauptmann, Ronald Kates, Monika Gräser, Rachel Wuerstlein, Hans H Kreipe, Oleg Gluz, null null
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Monika Gräser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer, Matthias Christgen, Jenci Palatty, Sherko Kuemmel, Eva-Maria Grischke, Doris Augustin, Michael Braun, Jochem Potenberg, Rachel Wuerstlein, Katja Krauss, Claudia Schumacher, Helmut Forstbauer, Toralf Reimer, Andrea Stefek, Hans Holger Fischer, Enrico Pelz, Christine Zu Eulenburg, Ronald Ernest Kates, Hua Ni, Cornelia Kolberg-Liedtke, Friedrich Feuerhake, Hans Heinrich Kreipe, Ulrike Nitz, Nadia Harbeck
Impact of RNA signatures on pCR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT-HER2+/HR- trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)